← Leaderboards
Scott E James
Sloan-Kettering Inst Can Research
$1,315,170
Attributed
$1,315,170
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,315,170 · 1
By mechanism
K08$1,315,170 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Hanzhi Luo$732,899
- Joseph Chai-Yuen Sun$17,368,196
- Luis F Parada$23,930,635
- Michael Kharas$18,485,709
- Joseph G Jurcic$858,939
Others in their field
Other Emerging Leaders on “Cellular Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$24,283,611
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Crystal Mackall · Children'S Hosp Of Philadelphia$14,376,798
- Barbara Burtness · Yale University$11,604,189
Research focus
Cellular ImmunotherapyAcute LeukemiaAcute Myeloid Leukemia CellAcute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAllogenicAntigen BindingAntigensAdultAutologousAwardAdvisory CommitteesBone MarrowBone Marrow CellsBone Marrow PurgingCar T Cell TherapyCd19 GeneCd 200Cd3 AntigensAntigen TargetingCell ModelCellsCell TherapyChemotherapy
Grant awards (5)
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia$263,034
K08 · FY2024 · CA · contact PI
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia$263,034
K08 · FY2023 · CA · contact PI
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia$263,034
K08 · FY2022 · CA · contact PI
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia$263,034
K08 · FY2021 · CA · contact PI
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia$263,034
K08 · FY2020 · CA · contact PI